Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis
European Journal of Clinical Microbiology & Infectious Diseases · 2026-07 · 45 (7) · 1941-1951
DOI: 10.1007/s10096-026-05482-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 20.03.2026. Verfasst von Changqin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China.
- Cardiovascular Ultrasound Center of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, China.
- Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China. zjyyxjq@163.com.
Förderung
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Chen, C., Mao, W., Zhao, C., Lu, D., Hu, W., & Xiong, J. (2026). Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis. European Journal of Clinical Microbiology & Infectious Diseases, 45(7), 1941-1951. https://doi.org/10.1007/s10096-026-05482-9
Vancouver
Chen C, Mao W, Zhao C, Lu D, Hu W, Xiong J. Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(7):1941-1951. doi:10.1007/s10096-026-05482-9
BibTeX
@article{Chen2026,
author = {Chen, Changqin and Mao, Wenchao and Zhao, Changyun and Lu, Difan and Hu, Weihang and Xiong, Jianqiang},
title = {Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2026},
volume = {45},
number = {7},
pages = {1941--1951},
doi = {10.1007/s10096-026-05482-9}
}
EUVIMED